F, M tt?S (2011) The usage of auditory event-related potentials in Alzheimer’s disease diagnosis. Int J Alzheimers Dis 2011:653173. 14. Garrido MI, Kilner JM, Stephan KE, Friston KJ (2009) The mismatch negativity: A evaluation of underlying mechanisms. Clin Neurophysiol 120(3):453?63. 15. Javitt DC, Schroeder CE, Steinschneider M, Arezzo JC, Vaughan HG, Jr. (1992) Demonstration of mismatch negativity within the monkey. Electroencephalogr Clin Neurophysiol 83(1):87?0. 16. Woodman GF (2011) The Oxford Handbook of Event-Related Potential Components, eds Kappenman ES, Luck SJ (Oxford University Press, New York). 17. Polich J (2007) Updating P300: An integrative theory of P3a and P3b. Clin Neurophysiol 118(10):2128?148. 18. Wieber J, Gugler R, Hengstmann JH, Dengler HJ (1975) Pharmacokinetics of ketamine in man. Anaesthesist 24(6):260?63. 19. Stoet G, Snyder LH (2006) Effects of your NMDA antagonist ketamine on task-switching performance: Proof for specific impairments of executive handle. Neuropsychopharmacology 31(8):1675?681.20. Taffe MA, Davis SA, Gutierrez T, Gold LH (2002) Ketamine impairs a number of cognitive domains in rhesus monkeys. Drug Alcohol Depend 68(2):175?87. 21. Meltzer HY, Stahl SM (1976) The dopamine hypothesis of schizophrenia: A critique. Schizophr Bull 2(1):19?6. 22. Goldberg TE, Weinberger DR (1996) Effects of neuroleptic drugs on the cognition of patients with schizophrenia: A evaluation of recent studies. J Clin Psychiatry 57(Suppl 9):62?5. 23. Foussias G, Remington G (2010) Antipsychotics and schizophrenia: From efficacy and effectiveness to clinical decision-making. Can J Psychiatry 55(three):117?25. 24. Korostenskaja M, K k en S (2009) What do ERPs and ERFs reveal concerning the effect of antipsychotic therapy on cognition in schizophrenia? Curr Pharm Des 15(22): 2573?593. 25. Luby ED, Gottlieb JS, Cohen BD, Rosenbaum G, Domino EF (1962) Model psychoses and schizophrenia.Potassium trichloroammineplatinate(II) site Am J Psychiatry 119:61?7.Fmoc-N,N-dimethyl-L-Asparagine Data Sheet 26. Zukin SR, Zukin RS (1979) Precise [3H]phencyclidine binding in rat central nervous system. Proc Natl Acad Sci USA 76(10):5372?376. 27. Kantrowitz JT, Javitt DC (2010) N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: The final widespread pathway around the road to schizophrenia? Brain Res Bull 83(3-4):108?21. 28. Swerdlow NR (2011) Are we studying and treating schizophrenia appropriately? Schizophr Res 130(1-3):1?0. 29. Seeman P, Guan H-C (2008) Phencyclidine and glutamate agonist LY379268 stimulate dopamine D2High receptors: D2 basis for schizophrenia. Synapse 62(11):819?28. 30. Javitt DC, Steinschneider M, Schroeder CE, Arezzo JC (1996) Part of cortical N-methylD-aspartate receptors in auditory sensory memory and mismatch negativity generation: Implications for schizophrenia.PMID:23357584 Proc Natl Acad Sci USA 93(21):11962?1967. 31. Umbricht D, Koller R, Vollenweider FX, Schmid L (2002) Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthier volunteers. Biol Psychiatry 51(5):400?06. 32. K k en S, et al. (2002) Dopamine modulates involuntary interest shifting and reorienting: An electromagnetic study. Clin Neurophysiol 113(12):1894?902. 33. Ueno A, et al. (2008) Auditory ERPs to stimulus deviance in an awake chimpanzee (Pan troglodytes): Towards hominid cognitive neurosciences. PLoS One particular 3(1):e1442. 34. Wylie GR, Clark EA, Butler PD, Javitt DC (2010) Schizophrenia patients show activity switching deficits consistent with N-methyl-d-aspartate technique dysfunction but not global executive deficits: Imp.
